 Connection
Kent Hutchison to Substance Withdrawal Syndrome
This is a "connection" page, showing publications Kent Hutchison has written about Substance Withdrawal Syndrome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.538 |
|
|
|
-
Thayer RE, Hutchison KE. Neuroimaging in clinical studies of craving: importance of reward and control networks. Psychol Addict Behav. 2013 Jun; 27(2):543-6.
Score: 0.355
-
Schacht JP, Selling RE, Hutchison KE. Intermediate cannabis dependence phenotypes and the FAAH C385A variant: an exploratory analysis. Psychopharmacology (Berl). 2009 Apr; 203(3):511-7.
Score: 0.259
-
Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction. 2008 Oct; 103(10):1678-86.
Score: 0.254
-
Palfai TP, Monti PM, Ostafin B, Hutchison K. Effects of nicotine deprivation on alcohol-related information processing and drinking behavior. J Abnorm Psychol. 2000 Feb; 109(1):96-105.
Score: 0.141
-
Ellingson JM, Bidwell LC, Hopfer CJ, Hutchison KE, Bryan AD. Correlates and Potential Confounds of Cannabis Withdrawal Among High-Risk Adolescents. J Stud Alcohol Drugs. 2019 09; 80(5):557-562.
Score: 0.137
-
Mon A, Durazzo TC, Gazdzinski S, Hutchison KE, Pennington D, Meyerhoff DJ. Brain-derived neurotrophic factor genotype is associated with brain gray and white matter tissue volumes recovery in abstinent alcohol-dependent individuals. Genes Brain Behav. 2013 Feb; 12(1):98-107.
Score: 0.085
-
Rohsenow DJ, Tidey JW, Miranda R, McGeary JE, Swift RM, Hutchison KE, Sirota AD, Monti PM. Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers. Exp Clin Psychopharmacol. 2008 Jun; 16(3):215-22.
Score: 0.063
-
Tanabe J, Crowley T, Hutchison K, Miller D, Johnson G, Du YP, Zerbe G, Freedman R. Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine. Neuropsychopharmacology. 2008 Feb; 33(3):627-33.
Score: 0.058
-
Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. Exp Clin Psychopharmacol. 2007 Feb; 15(1):81-92.
Score: 0.057
-
David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res. 2003 Dec; 5(6):935-42.
Score: 0.046
-
Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J Abnorm Psychol. 2000 Nov; 109(4):738-42.
Score: 0.037
-
Hutchison KE, Monti PM, Rohsenow DJ, Swift RM, Colby SM, Gnys M, Niaura RS, Sirota AD. Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results. Psychopharmacology (Berl). 1999 Feb; 142(2):139-43.
Score: 0.033
-
McClernon FJ, Hutchison KE, Rose JE, Kozink RV. DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues. Psychopharmacology (Berl). 2007 Nov; 194(4):433-41.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|